NCT04995783终止不适用
Predicting Medication Response for Autoimmune Disease
Coral Genomics, Inc.1 个研究点 分布在 1 个国家目标入组 200 人开始时间: 2020年9月1日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 终止
- 发起方
- 入组人数
- 200
- 试验地点
- 1
- 主要终点
- Prediction of medication response
研究概览
简要总结
Coral is conducting a large study comparing and predicting the relative effectiveness of different medications for autoimmune patients.
Patients with Inflammatory Bowel Disease (IBD) who have been diagnosed with either Ulcerative Colitis or Crohn's Disease and are undergoing treatment are eligible to participate.
Patients with Rheumatoid Arthritis (RA) and Psoriasis (Ps) will also be enrolled.
A novel clinical test will be performed to predict the responsiveness of a particular patient to different immune modulating therapies used in these conditions.
研究设计
- 研究类型
- Observational
- 观察模型
- Case Control
- 时间视角
- Other
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Ulcerative Colitis, Crohn's Disease, Rheumatoid Arthritis, Psoriasis diagnosis
- •On or about to begin a treatment for condition above
排除标准
- 未提供
结局指标
主要结局
Prediction of medication response
时间窗: retrospective and 6 months prospectively
AUC measure
次要结局
- Classification of disease(at enrollment)
- Prediction of disease severity(at enrollment)
研究者
研究点 (1)
Loading locations...
相似试验
已完成
4 期
Pharmacokinetics of Immunosuppressants in Renal Transplant Candidates Who Have Undergone Laparoscopic Sleeve GastrectomyEnd Stage Renal DiseaseNCT02221583University of Cincinnati26
招募中
4 期
Optimized Predictive Treatment In Medications for Unipolar Major Depression (OPTIMUM-D)Major Depressive DisorderNCT05017311Nova Scotia Health Authority400
招募中
不适用
IMPACT - AndHealth Autoimmune Research RegistryArthritis, RheumatoidArthritis, PsoriaticPsoriasisAutoimmune DiseasesAnkylosing SpondylitisNCT05883371AndHealth2,500
Unknown
3 期
Study of TQB2303 in Patients With CD20-Positive Diffuse Large B-cell Lymphoma (DLBCL)Diffuse Large B-cell LymphomaNCT03777085Chia Tai Tianqing Pharmaceutical Group Co., Ltd.230
招募中
3 期
Treatment of Rheumatoid Arthritis With DMARDs: Predictors of ResponseRheumatoid ArthritisNCT03414502University of Nebraska400